Literature DB >> 130178

Effects of drugs acting on cerebral 5-hydroxytryptamine mechanisms on dopamine-dependent turning behaviour in mice.

J A Milson, C J Pycock.   

Abstract

1. The effects of drugs acting on cerebral 5-hydroxytryptaminergic mechanisms on drug-induced turning behaviour in mice with unilateral destruction of nigro-striatal dopaminergic nerve terminals have been studied. 2. Administration of L-tryptophan (400 mg/kg) or 5-hydroxytryptophan (200 mg/kg) increased brain 5-hydroxytryptamine and decreased the turning induced by both apomorphine (2 mg/kg) and amphetamine (5 mg/kg). 3. Parachlorophenylalanine (3 X 500 mg/kg) decreased brain 5-hydroxytryptamine and increased both apomorphine and amphetamine-induced circling behaviour. 4. Varying the protein content of dietary intake significantly altered brain 5-hydroxytryptamine and tryptophan levels, spontaneous locomotor activity and amphetamine-induced circling behaviour in these mice. 5. Systemic administration of methysergide (0.5-4 mg/kg), lysergic acid diethylamide (0.025-0.2 mg/kg), cyproheptadine (2.5-20 mg/kg) or clomipramine (0.6-20 mg/kg) produced no consistent effect on drug-induced turning behaviour. 6. The results suggest that circling behaviour due to striatal dopamine receptor stimulation is depressed by an elevation of brain 5-hydroxytryptamine and enhanced by a reduction in brain 5-hydroxytryptamine. 7. The possible physiological relationship between dopamine and 5-hydroxytryptamine neurones in the basal ganglia is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 130178      PMCID: PMC1666754          DOI: 10.1111/j.1476-5381.1976.tb06961.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  51 in total

1.  Differential effects of serotonin on turning and sterotypy induced by apomorphine.

Authors:  R J Baldessarini; T T Amatruda; F F Griffith; S Gerson
Journal:  Brain Res       Date:  1975-07-25       Impact factor: 3.252

2.  Fine structural synaptic organization of the corpus striatum and substantia nigra in rat and cat.

Authors:  I J Bak; W B Choi; R Hassler; K G Usunoff; A Wagner
Journal:  Adv Neurol       Date:  1975

3.  Letter: LSD and dopamine receptors.

Authors:  C Pycock; G Anlezark
Journal:  Nature       Date:  1975-09-04       Impact factor: 49.962

4.  THE ESTIMATION OF SMALL QUANTITIES OF 3,4-DIHYDROXYPHENYLETHYLAMINE IN TISSUES.

Authors:  R LAVERTY; D F SHARMAN
Journal:  Br J Pharmacol Chemother       Date:  1965-04

5.  A SENSITIVE METHOD FOR SPECTROPHOTOFLUOROMETRIC ASSAY OF CATECHOLAMINES.

Authors:  C C CHANG
Journal:  Int J Neuropharmacol       Date:  1964-12

6.  Biochemical observations on LSD-25 and Deseril.

Authors:  W DOEPFNER
Journal:  Experientia       Date:  1962-06-15

7.  Serotonergic and antiserotonergic influences on apomorphine-induced stereotyped behaviour.

Authors:  W J Weiner; C Goetz; H L Klawans
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975-02

8.  Light and electron microscopic autoradiography of substantia nigra of rat after intraventricular administration of tritium labelled norepinephrine, dopamine, serotonin and the precursors.

Authors:  J Parizek; R Hassler; I J Bak
Journal:  Z Zellforsch Mikrosk Anat       Date:  1971

9.  Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.

Authors:  P F Von Voigtlander; K E Moore
Journal:  Neuropharmacology       Date:  1973-05       Impact factor: 5.250

10.  Uptake of (3H)5-hydroxytryptamine and (3H)noradrenaline by slices of rat brain incubated in plasma from patients treated with chlorimipramine, imipramine or amitroptyline.

Authors:  J R Tuck; G Punell
Journal:  J Pharm Pharmacol       Date:  1973-07       Impact factor: 3.765

View more
  11 in total

1.  Competitive antagonism by phentolamine of responses to biogenic amines and the transmitter at a neuroglandular junction.

Authors:  F Bowser-Riley; C R House; R K Smith
Journal:  J Physiol       Date:  1978-06       Impact factor: 5.182

2.  Specificity of monoamine neurotoxins: rotational responses to dopaminergic agonists after unilateral 6-OHDA and 5,6-DHT lesions of the median forebrain bundle [proceedings].

Authors:  J L Waddington; T J Crow
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

3.  Rotational behavior induced by 8-hydroxy-DPAT, a putative 5HT-1A agonist, in 6-hydroxydopamine-lesioned rats.

Authors:  R Gerber; C A Altar; J M Liebman
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Rotational responses to the putative serotonin agonist 5MeODMT following unilateral 5,6-DHT lesions of the median forebrain bundle: a possible role for 5-HT in the control of rotational behaviour [proceedings].

Authors:  T J Crow; J L Waddington
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

5.  Methodological problems in the measurement of drug-induced rotational behaviour: continuous recording reveals time-course differences undetected by previous techniques.

Authors:  J L Waddington; T J Crow
Journal:  Psychopharmacology (Berl)       Date:  1978-07-06       Impact factor: 4.530

6.  A preliminary study on the behaviour and biochemical responses subsequent to the injection of 5,6-dihydroxytryptamine into the substantia nigra of the rat.

Authors:  N N Osborne; V Neuhoff; K H Sontag; S Wolfarth
Journal:  Experientia       Date:  1978-04-15

7.  The influence of cerebral 5-hydroxytryptamine on catalepsy induced by brain-amine depleting neuroleptics or by cholinomimetics.

Authors:  L D Fuenmayor; M Vogt
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

8.  Mesolimbic dopamine neurons: effects of 6-hydroxydopamine-induced destruction and receptor blockade on drug-induced rotation of rats.

Authors:  P H Kelly; K E Moore
Journal:  Psychopharmacology (Berl)       Date:  1977-11-24       Impact factor: 4.530

Review 9.  Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease.

Authors:  P Jenner; M Sheehy; C D Marsden
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

10.  The influence of L-tryptophan and monoamine oxidase inhibitors on catecholamine metabolism in rat brain.

Authors:  D Eccleston; N Nicolaou
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.